These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12908355)

  • 1. [Increasing drug costs. The society's drug expenditures are strongly increasing. If this trend continues we have to make other priorities].
    Andreasen J
    Ugeskr Laeger; 2003 Jul; 165(29):2873-6. PubMed ID: 12908355
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 3. Study shows increases in drug costs may be justified by improvements in outcomes.
    Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-altered states. As pharmaceutical spending continues to soar, state legislatures are taking bold steps to rein in their costs.
    Tieman J
    Mod Healthc; 2002 Apr; 32(17):28-31. PubMed ID: 12024771
    [No Abstract]   [Full Text] [Related]  

  • 5. Expenditures for prescription drugs: too much or not enough?
    Schumock GT; Walton SM
    Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription drug trend begins showing modest slowdown.
    Capitation Rates Data; 2002 Jul; 7(7):76-80. PubMed ID: 12164063
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug atlas corrects political reproaches: why drug expenditures of GKV are really increasing].
    Schmidt K
    MMW Fortschr Med; 2007 Mar; 149(9):50-1. PubMed ID: 17612254
    [No Abstract]   [Full Text] [Related]  

  • 9. Plans confront specialty pharmacy's escalating costs in variety of ways.
    Reinke T
    Manag Care; 2010 Dec; 19(12):12-3, 15-6, 19. PubMed ID: 21291126
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug costs may top $750 PMPY by 2004.
    Capitation Rates Data; 2000 Oct; 5(10):115-8. PubMed ID: 11147537
    [No Abstract]   [Full Text] [Related]  

  • 11. Datawatch: Update on Rx drug spending.
    Bus Health; 2001 Sep; 19(8):48. PubMed ID: 11665673
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001.
    Jackevicius CA; Tu K; Filate WA; Brien SE; Tu JV;
    Can J Cardiol; 2003 Nov; 19(12):1359-66. PubMed ID: 14631469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of medicines in Canada.
    Han D; Wang EC
    Can J Clin Pharmacol; 2005; 12(1):e10-21. PubMed ID: 16055940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do higher drug costs lead to better health?
    Mintzes B; Lexchin J
    Can J Clin Pharmacol; 2005; 12(1):e22-7. PubMed ID: 16055941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defying the prescription. Forget forecasts--drug sales soar under managed care.
    Hensley S
    Mod Healthc; 1998 Apr; 28(15):42. PubMed ID: 10178321
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug utilization: national and international comparisons.
    Yosselson-Superstine S
    Isr J Med Sci; 1992 Oct; 28(10):728-30. PubMed ID: 1399504
    [No Abstract]   [Full Text] [Related]  

  • 20. [Priorities by the board of drug benefits--guidelines clarify. Clinical trials are not sufficient for decisions on subsidizing].
    Carlsson P
    Lakartidningen; 2003 Jul; 100(30-31):2428-9. PubMed ID: 12914137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.